(Q50933524)

25 March 2018

title

Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. (English)

1 reference

25 March 2018

1 reference

3

1 reference

25 March 2018

author name string

Srinivas Basavoju

series ordinal

1

1 reference

25 March 2018

Dan Boström

series ordinal

2

1 reference

25 March 2018

publication date

17 August 2007

1 reference

25 March 2018

published in

Pharmaceutical Research

1 reference

25 March 2018

volume

25

1 reference

25 March 2018

issue

3

1 reference

25 March 2018

page(s)

530-541

1 reference

25 March 2018

Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids

cites work

1 reference

12 December 2020

Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance

1 reference

12 December 2020

Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding

1 reference

12 December 2020

Reaction crystallization of pharmaceutical molecular complexes

1 reference

12 December 2020

Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

1 reference

12 December 2020

Cocrystal formation during cogrinding and storage is mediated by amorphous phase

1 reference

12 December 2020

Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization

1 reference

12 December 2020

Pharmaceutical co-crystals

1 reference

12 December 2020

Crystal engineering of the composition of pharmaceutical phases.

1 reference

12 December 2020

Amorphous drug delivery systems: molecular aspects, design, and performance.

1 reference

12 December 2020

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

1 reference

12 December 2020

Physical stability enhancement of theophylline via cocrystallization.

1 reference

12 December 2020

Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?

1 reference

12 December 2020

The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids

1 reference

12 December 2020

Crystallization of indomethacin from the amorphous state below and above its glass transition temperature

1 reference

12 December 2020

Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.

1 reference

12 December 2020

Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability

1 reference

12 December 2020

1 reference

12 December 2020

Reactivity differences of indomethacin solid forms with ammonia gas

1 reference

12 December 2020

10.1007/S11095-007-9394-1

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018